{
    "nctId": "NCT03444142",
    "officialTitle": "Effect of the Weekly Administration of Exenatide LAR or Dulaglutide on the Variability of Blood Pressure and Heart Rate of 24 Hours in Patients With Type 2 Diabetes Mellitus Without Pharmacological Treatment.",
    "inclusionCriteria": "* Patients both sexes\n* Age between 31 and 60 years\n* Diagnosis of diabetes according ADA criteria:\n\n(Fasting blood glucose levels \\>125 mg/dl or postprandial blood glucose levels after an oral glucose tolerance test with 75 of oral glucose \\> 200 mg/dl, or glycosylated hemoglobin \\>6.5%).\n\n\u2022 Informed consent signed\n* Must have minimum age of 31 Years\n* Must have maximum age of 60 Years",
    "exclusionCriteria": "* Women with confirmed or suspected pregnancy\n* Women under lactation and/or puerperium\n* Hypersensibility to ingredients of intervention\n* Physical impossibility for apply the drug\n* Known pancreatic, renal, hepatic, heart or thyroid diseased\n* Hypertension diagnosis\n* Previous treatment for glucose\n* Body Mass Index \u226539.9 kg/m2\n* Triglycerides \u2265500 mg/dL\n* Total cholesterol \u2265300 mg/dL\n* Night or rotating shift workers\n* Blood Pressure \u2265140/90 mmHg"
}